Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weidong Han

Showing results (171-180 of 392) with videos related to

Pageof 40
Sort By:
Cellular & Molecular Immunology|October 1, 2020
Clinical development of CAR T cell therapy in China: 2020 updateJianshu Wei, Yelei Guo, Yao Wang, et al.
Life Sciences|November 6, 2012
Effects of Rehmannia glutinosa oligosaccharide on human adipose-derived mesenchymal stem cells in vitroYu Zhang, Yuhong Wang, Lei Wang, et al.
Archives of Gynecology and Obstetrics|June 15, 2016
The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysisLuyang Zhao, Chenglei Gu, Ke Huang, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2016
Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497Lin Liu, Lin Chen, Xuan Wu, et al.
Plos One|February 9, 2013
The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expressionLin Liu, Jing Nie, Lin Chen, et al.
Current Protein & Peptide Science|May 2, 2015
The Accomplices of NF-κB Lead to RadioresistanceMiaomiao Bai, Xiaoxing Ma, Xiaolei Li, et al.
Scientific Reports|May 23, 2018
Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER databaseSujing Jiang, Rongjie Zhao, Yiran Li, et al.
Nucleic Acids Research|May 7, 2009
FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cellsWeidong Han, Zhiqiang Wu, Yali Zhao, et al.
Oncotarget|August 26, 2015
The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patientsXinbing Sui, Junhong Ma, Weidong Han, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
Erratum: RPL32 Promotes Lung Cancer Progression by Facilitating p53 DegradationJiansheng Xie, Wei Zhang, Xiaojing Liang, et al.
Pageof 40

Showing results (171-180 of 392) with videos related to

Sort By:
Pageof 40
Cellular & Molecular Immunology|October 1, 2020
Clinical development of CAR T cell therapy in China: 2020 updateJianshu Wei, Yelei Guo, Yao Wang, et al.
Life Sciences|November 6, 2012
Effects of Rehmannia glutinosa oligosaccharide on human adipose-derived mesenchymal stem cells in vitroYu Zhang, Yuhong Wang, Lei Wang, et al.
Archives of Gynecology and Obstetrics|June 15, 2016
The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysisLuyang Zhao, Chenglei Gu, Ke Huang, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2016
Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497Lin Liu, Lin Chen, Xuan Wu, et al.
Plos One|February 9, 2013
The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expressionLin Liu, Jing Nie, Lin Chen, et al.
Current Protein & Peptide Science|May 2, 2015
The Accomplices of NF-κB Lead to RadioresistanceMiaomiao Bai, Xiaoxing Ma, Xiaolei Li, et al.
Scientific Reports|May 23, 2018
Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER databaseSujing Jiang, Rongjie Zhao, Yiran Li, et al.
Nucleic Acids Research|May 7, 2009
FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cellsWeidong Han, Zhiqiang Wu, Yali Zhao, et al.
Oncotarget|August 26, 2015
The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patientsXinbing Sui, Junhong Ma, Weidong Han, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
Erratum: RPL32 Promotes Lung Cancer Progression by Facilitating p53 DegradationJiansheng Xie, Wei Zhang, Xiaojing Liang, et al.
Pageof 40